Kinect Sensor in Cerebral Palsy Children: Phase 2.1

The Engineer-built System, Video-game Based Kinect Sensor in Upper Extremities Problems in Cerebral Palsy Children: Phase 2.1

NCT05338229•Mahidol University

View on ClinicalTrials.gov

Summary

There are 3 phases of the study. This registration is phase 2.1.This registration will conduct a pilot study in the cerebral palsy children.

Eligibility

Age

10 - 15 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Spastic cerebral palsy aged 10-15 years
•Sufficient cognitive/attention capacity to understand basic instructions
•Can cooperate with the therapist for short period of time during training
•Manual Ability Classification System (MACS) 2-3
•Zancolli classification of the affected upper extremity was grade I-II.
•Give the informed consent

Exclusion Criteria

•Inability to understand the instruction and follow the task
•Severe comorbidities, visual or auditory impairment
•Had history of Botulinum toxin injection on the affected upper extremity for last 6 months or receive the injection during the study time
•Other treatment options planned on the affected upper extremity during the study time
•Wear daytime orthosis on the affected limb
•Zancolli classification of the affected hand was grade III.
•Got an epilepsy or convulsive condition
•Denied to give the informed consent or continue the study

Key Dates

Start Date

June 1, 2022

Primary Completion Date

December 1, 2022

Completion Date

December 1, 2022

Last Updated

September 19, 2022

Conditions

Cerebral Palsy ChildrenUpper Extremity Problem

Interventions

the engineer-built system, video-game based Kinect sensor

DEVICE

Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy

NCT06811545

Cerebral Palsy ChildrenHealthy Adults

View study

COMPLETED

Dominant Non-Dominant Upper Extremity in Gender

NCT06269887

Upper Extremity ProblemGender Issues

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Kinect Sensor in Cerebral Palsy Children: Phase 2.1

Inclusion Criteria

Exclusion Criteria

Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy

Dominant Non-Dominant Upper Extremity in Gender

Pain, Range of Motion, Edema, Sensibility, Strength (PRESS) & Self-reported Function Create a Comprehensive Score

Effectiveness of Robot-Assisted Upper Extremity Rehabilitation in Children With Cerebral Palsy

Arm Swing During Walking in Early Multiple Sclerosis

Effects of Action Observation Therapy and Video-Based Play Therapy on Children With Unilateral Cerebral Palsy